Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: It is unknown whether insulin therapy can delay or prevent diabetes in nondiabetic relatives of patients with diabetes. METHODS: In a randomized, controlled, nonblinded clinical trial, we screened 84,228 first-degree and second-degree relatives of patients with diabetes for islet-cell antibodies; 3152 tested positive; 2103 of the 3152 underwent genetic, immunologic, and metabolic staging to quantify their risk; 372 of the 2103 had a projected five-year risk of more than 50 percent; 339 of the 372 (median age, 11.2 years) were randomly assigned to undergo either close observation or an intervention that consisted of low-dose subcutaneous ultralente insulin, administered twice daily for a total dose of 0.25 unit per kilogram of body weight per day, plus annual four-day continuous intravenous infusions of insulin. Oral glucose-tolerance tests were performed every six months. Median follow-up was 3.7 years. The primary end point was a diagnosis of diabetes. RESULTS: Diabetes was diagnosed in 69 subjects in the intervention group and 70 subjects in the observation group. The annualized rate of progression to diabetes was 15.1 percent in the intervention group and 14.6 percent in the observation group. The cumulative incidence of diabetes was similar in the two groups (relative risk in the intervention group as compared with the observation group, 0.96). Most subjects in whom diabetes developed were asymptomatic. Progression to diabetes occurred at a faster rate among subjects with abnormal base-line glucose tolerance (22 percent per year) than among those with normal base-line glucose tolerance (10 percent per year, P<0.001). There were no episodes of severe hypoglycemia. The incidence of chemical hypoglycemia, assessed without ascertainment bias, was similar in the two groups. CONCLUSIONS: In persons at high risk for diabetes, insulin at the dosage used in this study does not delay or prevent type 1 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but subgroup analyses suggested a benefit of oral insulin in individuals with the highest titres of insulin auto-antibodies.142,143”
From Type 1 diabetes (2018) · cites this paper as [142]
In the citing paper
“The Diabetes Prevention Trial—Type 1, tested whether oral or parental insulin prevented the development of type 1 diabetes in people who were autoantibody positive. Neither approach reduced diabetes development,”
From Type 1 diabetes (2018) · cites this paper as [142]
In the citing paper
“If one islet autoantibody is found, the test should be repeated and the other autoantibodies should be assayed because the risk of type 1 diabetes increases if two or more autoantibodies are positive (443).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [443]
In the citing paper
“Subcutaneously or intranasally delivered insulin was found to have no preventive effects.39,48”
From The future of type 1 diabetes therapy (2025) · cites this paper as [48]
In the citing paper
“Risk can be assessed by islet cell autoantibodies alone, without the need for evaluating endogenous insulin reserves, as was done for the U.S. DPT-1 trial (306).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [306]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420
Cognitive Deficits in Adolescents Who Developed Diabetes Early in Life
Ryan, C., Vega, A., & Drash, A. (1985) · Pediatrics · doi:10.1542/peds.75.5.921 · Cited by 413
Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy
Atkinson, M. A., Maclaren, N. K., & Luchetta, R. (1990) · Diabetes · doi:10.2337/diab.39.8.933 · Cited by 299
Insulin prophylaxis in individuals at high risk of type 1 diabetes
Keller, R. J., Jackson, R. A., Eisenbarth, G. S., & Eisenbarth, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91215-8 · Cited by 298
Pugliese, A., Gianani, R., Moromisato, R., Awdeh, Z. L., Alper, C. A., Erlich, H. A., Jackson, R. A., & Eisenbarth, G. S. (1995) · Diabetes · doi:10.2337/diab.44.6.608 · Cited by 207
Gotfredsen, C. F., Buschard, K., & Frandsen, E. K. (1985) · Diabetologia · doi:10.1007/bf00703140 · Cited by 205
Vardi, P., Dib, S. A., Tuttleman, M., Connelly, J. E., Grinbergs, M., Radizabeh, A., Riley, W. J., Maclaren, N. K., Eisenbarth, G. S., & Soeldner, J. S. (1987) · Diabetes · doi:10.2337/diab.36.11.1286 · Cited by 192
Attentional Functioning in Children and Adolescents With IDDM
Rovet, J., & Alvarez, M. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.803 · Cited by 153
Cited by
Items 701–800 of 832
Early Diagnosis of Type 1 Diabetes – Useful or a Pyrrhic Victory?
Pozzilli, P., & Pieralice, S. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch2 · Cited by 1
Johnson, S. B. (2010) · Issues in clinical child psychology · doi:10.1007/978-1-4419-5800-6_12 · Cited by 1
Immunopathogenesis of Type 1 Diabetes in Western Society
Paronen, J., & Eisenbarth, G. S. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0407 · Cited by 1
Editorial Comment on type 1 diabetes and antigen-specific immunotherapy
Lernmark, Å., & Larsson, H. E. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02412.x · Cited by 1
Preservation of beta cell function
Sperling, M. A. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00675.x · Cited by 1
Immunology of Type 1 Diabetes Mellitus
Pietropaolo, M., Zhang, Y., & Trucco, M. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0507-5_2 · Cited by 1
Immune and cell therapy in type 1 diabetes: too little too late?
Gillard, P., & Mathieu, C. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.560568 · Cited by 2
Mechanisms underlying type 1 diabetes and islet transplantation
Yu, J., & Eisenbarth, G. S. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.05.001 · Cited by 1
Type 1 Diabetes: Clinical and Experimental
Chiarelli, F., & Marcovecchio, M. L. (2010) · Yearbook of pediatric endocrinology · doi:10.1159/000320658 · Cited by 1
Immunological profile and aspects of immunotherapy in type 1 diabetes
Hjorth, M. (2010) · DiVA (Linkoping University) · Cited by 1
Screening for Diabetes and Glucose Intolerance
Shaw, J. E., Dowse, G. K., Zimmet, P., & Alberti, K. G. M. M. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1101 · Cited by 1
Geenen, V., Brilot, F., Hansenne, I., Louis, C., Renard, C., & Martens, H. (2004) · CRC Press eBooks · doi:10.1201/9780203021941-20 · Cited by 2
Lempainen, J. (2009) · UTUPub (University of Turku) · Cited by 1
The role of cytokines in the pathogenesis of autoimmune diabetes, immune intervention issues
Кravets, Y. B., Саприна, Т. В., Лазаренко, Ф. Э., Prokhorenko, T. S., & Ryazantsevа, N. V. (2010) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2010-1-76-83 · Cited by 1
Diabetes mellitus Typ 1: Ätiologie und Pathogenese
Scherbaum, W. A., & Kolb, H. (2004) · Springer eBooks · doi:10.1007/978-3-642-18571-7_3 · Cited by 1
Ambler, G. R., Cameron, F. J., Joshi, K., & Wherrett, D. K. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch15 · Cited by 1
Hirsch, I. B. (2002) · Clinical Diabetes · doi:10.2337/diaclin.20.4.162 · Cited by 1
Prevention of Type 1 Diabetes Mellitus
Pozzilli, P., & Guglielmi, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_49-1 · Cited by 1
Genetics and Epigenetics of Type 1 Diabetes Self-Reactive T Cells
Kang, T. G., & Youngblood, B. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041586 · Cited by 3
Katsarou, A., Holm, B., Lynch, K. F., & Lernmark, Å. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-517-6_11 · Cited by 1
Zawatsky, C. L. B. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Targeted Therapies in Autoimmune and Inflammatory Skin Disorders
Eming, R., & Tarner, I. H. (2011) · Springer eBooks · doi:10.1007/978-3-211-99225-8_24
Immunotherapies for Type 1 Diabetes
Gürr, W. (2013) · InTech eBooks · doi:10.5772/54717
Ingested Type I Interferon in Experimental Autoimmune Encephalomyelitis
Brod, S. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-905-2:163
Detection and Treatment of Type 1 Diabetes
Mazze, R. S., APRN-BC, F. E. S. S., Bergenstal, R. M., Criego, A. B., Cuddihy, R. M., Langer, O., Simonson, G. D., & Powers, M. A. (2011) · Wiley eBooks · doi:10.1002/9781119950424.ch4
Harrison, L. C., Fourlanos, S., Every, A. L., Honeyman, M. C., Steptoe, R. J., Martinez, N. R., Jensen, K. P., Funda, D. P., Mannering, S. I., Colman, P. G., et al. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1117
Campaña, A. B. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2008.tde-16092008-111556
Islet antigen-specific T cells and regulatory T cells in type 1 diabetes
Öling, V. (2010) · UTUPub (University of Turku)
Prevention Opportunities of Type 1 Diabetes in Children
Saghir, A. (2015) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2015.02.00017
Frühdiagnostik bei Typ-1-Diabetes
Achenbach, P., Pan, L., & Ziegler, A. (2007) · Der Diabetologe · doi:10.1007/s11428-007-0191-6 · Cited by 3
Okumachi, Y., Moriyama, H., Kameno, M., Arai, T., Kishi, M., Kurohara, M., Yamada, K., Yasuda, H., Hara, K., Yokono, K., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.066
Keeping the patient perspective: Where are we in the world of type 1 diabetes?
Pettus, J., & von Herrath, M. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.08.003
Lee, M., & Kim, K. (2009) · Journal of Korean Medical Association · doi:10.5124/jkma.2009.52.7.677
Antigen specific treatment for the inhibition and remission of type 1 diabetes
Abiru, N. (2008) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.31.432
Aspectos clínicos y diagnósticos de la diabetes infantil
Bouhours‐Nouet, N., & Coutant, R. (2011) · EMC - Pediatría · doi:10.1016/s1245-1789(11)71180-5 · Cited by 2
The Clinical Heterogeneity of Adult-Onset Diabetic Patients With GAD Autoantibodies in Japan
Kawasaki, E., Osawa, H., Makino, H., & Ehime Diabetes Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2364
Treg Vaccination with a Strong-Agonistic Insulin Mimetope
Weigmann, B., & Daniel, C. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0295-2 · Cited by 1
Highlights of Frontiers In Autoimmunity: Fundamental Aspects and Clinical Perspectives
Hasler, P., & Zouali, M. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.1.125
Prevention of type 1 diabetes: Where do we start?
Pozzilli, P., & Adorini, L. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345174
Tratamiento de la diabetes en el niño y en el adolescente
Boileau, P., Merle, B., & Bougneres, P. F. (2005) · EMC - Pediatría · doi:10.1016/s1245-1789(05)43854-8
Yamada, S., Shimada, A., Kodama, K., Morimoto, J., Suzuki, R., Oikawa, Y., Irie, J., & Saruta, T. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.028
Type 1A diabetes: a predictable but not yet preventable autoimmune syndrome
Eisenbarth, G. S. (2007) · Practical Diabetes · doi:10.1002/pdi.1053
MYELOID CELLS IN AUTOIMMUNE DISEASES
Mia, M. S. (2014) · Figshare
Studies of Mucosal Immune Regulation in Celiac Disease and Type 1 Diabetes
Lahdenperä, A. I. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-110687
Autoantibodies related to type 1 diabetes in children
Skoglund, C. (2011) · DiVA (Linkoping University)
Preventive Interventions for Type 1 Diabetes: History, Appraisal and Prospects
Dupre, J., Jeffrey, L., & Mahon (2007) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(07)14011-9
Strategies to treat autoimmune diabetes
Filippi, C. M., & von Herrath, M. G. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.2.185
Autoimmune markers in autoimmune diabetes
Gupta, M. (2003) · Figshare
Light at the end of the tunnel?
Sperling, M. A. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00397.x
Greenbaum, C. J., Schatz, D., Haller, M. J., & Sanda, S. (2012) · Diabetes · doi:10.2337/db12-0914
Autoantibodies as markers of beta-cell autoimmunity in children
Holmberg, H. (2006) · DiVA (Linkoping University)
Réduction du risque de diabète
Ransom, T. P. P., Goldenberg, R., Mikalachki, A., Prebtani, A. P. H., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.033 · Cited by 2
Sanjeevi, C. B., & Sun, C. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_19
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Aragona, M., & Prato, S. D. (2006) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2006.00.01.1f
Prevalence, public health aspects and prevention of diabetes
Dyson, P. A. (2015) · Wiley eBooks · doi:10.1002/9781119121725.ch1 · Cited by 1
Molecular Basis for Induction of Tolerance in Type I Diabetes
Candon, S., Chatenoud, L., & Bach, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-36003-4_6
Quale terapia precoce per il diabete autoimmune dell’adulto?
Pozzilli, P., & Maurizi, A. R. (2011) · L Endocrinologo · doi:10.1007/bf03344774
"Persistence of Diabetes" - Why Has Research into Type 1 Diabetes not Made Significant Advances?
Sia, C., & Weinem, M. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.156
Role of Regulatory T Cells in the Prevention of Diabetes by Insulin in NOD Mice
Karounos, D. G. (2012) · Journal of Clinical & Cellular Immunology · doi:10.4172/scientificreports.161
Saravanan, S. L., & Mohanty, R. (2011) · InnovAiT Education and inspiration for general practice · doi:10.1093/innovait/inr172
Antigen-based prediction and prevention of type 1 diabetes.
Petersen, J. S. (2006) · PubMed · Cited by 2
Étude Pre-POINT : effets immunologiques de l’insuline orale à forte dose
Dubois‐Laforgue, D. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30100-6
Nanoparticles, Interleukin-10 and Autoimmune Diabetes
Mandke, R., Basarkar, A., & Singh, J. (2012) · Science Publishers eBooks · doi:10.1201/b11775-19
Biologic Therapies For Type 1 Diabetes
Belle, T. V., & von Herrath, M. (2009) · CRC Press eBooks · doi:10.1201/9781420063219.ch9
Type 1 diabetes: immunology, genetics and epidemiology
Fourlanos, S., & Kay, T. W. H. (2003) · CRC Press eBooks · doi:10.3109/9780203502976-5
Pathophysiology of Type 1 Diabetes
Meneghini, L. (2007) · CRC Press eBooks · doi:10.3109/9780849326233-4
Peptide-Based Instruction of Suppressor Commitment in Naïve T Cells
Apostolou, I., Kretschmer, K., & von Boehmer, H. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50013-5
Public Health Genomics of Type 1 Diabetes, Type 2 Diabetes, and Diabetic Complications
Hanson, R. L., Nelson, R. G., & Knowler, W. C. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195317060.003.0028
Makori, W. A. (2016) · Kenyatta University Institutional Repository (Kenyatta University)
Duncan, A. (2016) · Research Portal (King's College London)
To boldly go—or to go too boldly? The accelerator hypothesis revisited
Huxley, T. H. (2007)
Jaramillo-Arango, C. (2017) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2017.05.00118
Nanopartículas de insulina para administração oral
Correia, C. J. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Skyler, J. S. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch37
Physiopathologie des états diabétiques
(2010) · Elsevier eBooks · doi:10.1016/b978-2-294-70868-8.50002-5
Physiopathologie des états diabétiques
Vialettes, B. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-73954-5.00002-0 · Cited by 1
Grotzke, M. P., & Jones, R. E. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00010-3
Autoimmune polyendocrine syndrome type II: After adrenal crisis
Palma, N. Z., da Cruz, M., Santos, L. R., Cruz, M., Cunha, F. M., Fagundes, V., Pires, L., & Mesquita, M. (2020) · Case Reports in Internal Medicine · doi:10.5430/crim.v7n2p3
Tracking the humoral immune response in type 1 diabetes
Bian, X. (2015)
Lord, S. M., & Greenbaum, C. J. (2021) · Kompass Autoimmun · doi:10.1159/000516244
Ishizuka, A. S., Lynn, G. M., & Jewell, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821440-4.00002-5
GAD65 An Immunomodulator in Type 1 Diabetes
Axelsson, S. (2012) · DiVA (Linkoping University)
Prediction, diagnosis, prevention and treatment: genetic-led care of patients with diabetes
Tangjittipokin, W., Borrisut, N., & Rujirawan, P. (2021) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.1970526
Incidence trends and environmental determinants of type 1 diabetes in Lithuania and Sweden
Pundziūtė-Lyckå, A. (2003) · DiVA (Digitala Vetenskapliga Arkivet)
Bach, J. (2003) · Springer eBooks · doi:10.1007/978-3-7091-6016-9_2
Skyler, J. S. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_15 · Cited by 1
Future Drug Treatment for Type 1 Diabetes
Larsson, H. E., Delli, A. J., Ivarsson, S. A., & Lernmark, Å. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch59
Therapy of Type 1 Diabetes Mellitus
Omura, E., & Peters, A. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_43-1
Therapy of Type 1 Diabetes Mellitus
Omura, E., Cohan, P., & Peters, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_43
Natural Evolution, Prediction and Prevention of Type 1 Diabetes in Youth
Taplin, C. E., & Barker, J. M. (2008) · CRC Press eBooks · doi:10.3109/9781420047981-13
The Main Events in the History of Diabetes Mellitus
Goldman, R., Zajac, J., Shrestha, A., Patel, P., & Poretsky, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_1-1
Marrack, P. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200608-150ms
Awareness of Effect Diabetes Type 1 on Quality of Life in school child Through Educational
(2017) · AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES · doi:10.22587/ajbas.2017.11.14.18
Physiopathologie des états diabétiques
(2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00002-6
Prädiktion und Prävention des Typ—1—Diabetes
(2006) · Springer eBooks · doi:10.1007/3-540-26602-x_4
Early Diagnosis of Type 1 Diabetes: Useful or a Phyrrhic Victory?
Guglielmi, C., & Pozzilli, P. (2011) · Wiley eBooks · doi:10.1002/9781444340280.ch2
Prevention of Autoimmune Disease: The Type 1 Diabetes Paradigm
Harrison, L. C., & Wentworth, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00070-1
Metadata
- Authors
- Diabetes Prevention Trial–Type 1 Diabetes Study Group
- Affiliations
- University of Miami (US)
- Corresponding author
- Diabetes Prevention Trial–Type 1 Diabetes Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-05-30
- Volume
- 346
- Issue
- 22
- Pages
- 1685-1691
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W614574849
- Cited by
- 836
- References
- 30
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 24 · 2023: 21 · 2022: 20 · 2021: 32 · 2020: 21 · 2019: 21 · 2018: 22 · 2017: 27 · 2016: 26 · 2015: 34 · 2014: 30 · 2013: 38 · 2012: 42
- FWCI
- 28.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK117009)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, insulin therapy, diabetes prevention, relatives of diabetic patients, islet cell antibodies, ultralente insulin, continuous intravenous insulin infusion, glucose tolerance, hypoglycemia, disease progression
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Diabetes Mellitus, Type 1, Family, Female, Glucose Tolerance Test, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Islets of Langerhans, Male, Middle Aged, Risk Factors, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.